Nephrotoxicity: Clinical Trials

4 trials for Nephrotoxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 active not recruiting, 1 completed. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Not yet recruiting 2, Active not recruiting 1, Completed 1
Phase 22Completed 1, Not yet recruiting 1

Follow Nephrotoxicity: new trials by email Literature Review of Nephrotoxicity trials Research Report on Nephrotoxicity

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Colistin Nephrotoxicity and Role of Alpha Lipoic Acid
alpha lipoic acid drug (thioctic acid acid) - Nephrotoxicity
Phase 3Not yet recruitingHelwan University882026-06-302026-06-25
Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity
Vitamin C, Coenzyme Q 10 - Nephrotoxicity
Phase 2 / Phase 3Not yet recruitingAin Shams University752026-04-202026-03-17
Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid in Colistin-Induced Nephrotoxicity
Addition of sachets of N-acetyl cysteine 1200 mg twice/day to the maintenance dose of colistin, Addition of Alpha-lipoic acid 600mg twice daily to the maintenance dose of colistin - Nephrotoxicity
Phase 2 / Phase 3CompletedAin Shams University1802024-11-012026-02-17
Cisplatin Disposition and Kidney Injury
Granisetron, Ondansetron, Palonosetron - Nephrotoxicity
Phase 3Active not recruitingUniversity of Colorado, Denver452019-11-152026-09-17

Narrower conditions

Neoplasms (1)

Interventions

Ascorbic Acid (1)  ·  Granisetron (1)  ·  Ondansetron (1)  ·  Palonosetron (1)  ·  Thioctic Acid (1)  ·  coenzyme Q10 (1)

Sponsors

Ain Shams University (2)  ·  Helwan University (1)  ·  University of Colorado, Denver (1)

Countries

Egypt (3)  ·  United States (1)

Top investigators

Dina H El Adly, MSc (1)  ·  Edgar Jaimes, MD (1)  ·  Eman Magdy Elsayed Elyamany, Assistant lecturer (1)  ·  Lamia M El Wakeel, PhD (1)  ·  Melanie Joy, PharmD, PhD (1)  ·  Nagwa A Sabri, PHD (1)

Results publications

PMID 38955285, PMID 39711135, PMID 39726772

NIH funding

R01GM123330 (1)